Related Experiment Video
Updated: Jan 24, 2026

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer
Tianzuo Zhan1,2, Giulia Ambrosi1, Anna Maxi Wandmacher1
1Division Signaling and Functional Genomics, German Cancer Research Center (DKFZ) and Heidelberg University, 69120, Heidelberg, Germany.
Abstract:
In colorectal cancer (CRC), aberrant Wnt signalling is essential for tumorigenesis and maintenance of cancer stem cells. However, how other oncogenic pathways converge on Wnt signalling to modulate stem cell homeostasis in CRC currently remains poorly understood. Using large-scale compound screens in CRC, we identify MEK1/2 inhibitors as potent activators of Wnt/β-catenin signalling. Targeting MEK increases Wnt activity in different CRC cell lines and murine intestine in vivo. Truncating mutations of APC generated by CRISPR/Cas9 strongly synergize with MEK inhibitors in enhancing Wnt responses in isogenic CRC models. Mechanistically, we demonstrate that MEK inhibition induces a rapid downregulation of AXIN1. Using patient-derived CRC organoids, we show that MEK inhibition leads to increased Wnt activity, elevated LGR5 levels and enrichment of gene signatures associated with stemness and cancer relapse. Our study demonstrates that clinically used MEK inhibitors inadvertently induce stem cell plasticity, revealing an unknown side effect of RAS pathway inhibition.
Insights
MEK inhibitors activate Wnt/β-catenin signalling in colorectal cancer (CRC) by downregulating AXIN1. This unintended effect increases cancer stemness and relapse potential, highlighting a critical side effect of RAS pathway inhibition.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Stem Cell Research
Background:
- Aberrant Wnt signalling drives colorectal cancer (CRC) tumorigenesis and cancer stem cell maintenance.
- The convergence of oncogenic pathways on Wnt signalling in CRC stem cell homeostasis is not well understood.
Purpose of the Study:
- To investigate how other oncogenic pathways interact with Wnt signalling in CRC.
- To identify therapeutic strategies targeting Wnt signalling in CRC.
Main Methods:
- Large-scale compound screens in CRC cell lines.
- CRISPR/Cas9 gene editing to generate APC mutations.
- In vivo studies in murine intestine.
- Analysis of patient-derived CRC organoids.
Main Results:
- MEK1/2 inhibitors were identified as potent activators of Wnt/β-catenin signalling in CRC.
- MEK inhibition led to downregulation of AXIN1, increasing Wnt activity.
- MEK inhibitors synergized with APC mutations to enhance Wnt responses.
- Increased Wnt activity, LGR5 levels, and stemness/relapse gene signatures were observed in CRC organoids.
Conclusions:
- Clinically used MEK inhibitors inadvertently promote stem cell plasticity in CRC.
- This reveals an unknown side effect of RAS pathway inhibition, impacting cancer stemness and relapse potential.
More Related Videos
07:29Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
11:53An Alternative Culture Method to Maintain Genomic Hypomethylation of Mouse Embryonic Stem Cells Using MEK Inhibitor PD0325901 and Vitamin C
Published on: June 1, 2018
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
What is Cell Signaling?
Cell-surface Signaling